Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals

Represented Avid in suit concerning amyloid beta technology and its use in animal models in searching for drugs to treat Alzheimer's disease (AD). Won a jury verdict for Avid on issue of inventorship and patent ownership that was affirmed by the Federal Circuit, and obtained a finding of exceptional case, entitling Avid to an award of attorneys' fees. The verdict disposed of a series of suits against numerous companies involved in scientific research relating to Alzheimer's disease.